The Skeptics @Majikthyse reveals madjik research skilz

21CFR601

Subpart F–Confidentiality of Information

Sec. 601.50

Confidentiality of data and information in an investigational new drug notice for a biological product

(a) The existence of an IND notice for a biological product will not be disclosed by the Food and Drug Administration unless it has previously been publicly disclosed or acknowledged

“The Skeptics™” #FAIL
======================================
REFERENCES:
======================================
[1] – Les Rose (@Majikthyse) tweeted at 2:21pm – 25 Sep 13:

@dianthusmed @cappsie Hmm…FDA refused my request, saying all info subject to IND is confidential. We shall see! #Burzynski

@dianthusmed @cappsie Hmm…FDA refused my request, saying all info subject to IND is confidential. We shall see! #Burzynski

— Les Rose (@Majikthyse) September 25, 2013

======================================
[2] – Code of Federal Regulations

Title 21, Volume 7

Revised as of April.1, 2013

TITLE 21–FOOD AND DRUGS

CHAPTER I–FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER F–BIOLOGICS

PART 601 LICENSING
——————————————————————
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=601&showFR=1&subpartNode=21:7.0.1.1.2.6
======================================

Advertisement